Cargando…
Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) generally require allogeneic hematopoietic cell transplantation (allo-HCT) for a cure, except for patients with favorable genetic genotypes such as those with core-binding factor AML. However, the use of intensive chemothe...
Autores principales: | Kim, Hee-Je, Weisdorf, Daniel, Gottlieb, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847286/ https://www.ncbi.nlm.nih.gov/pubmed/36713469 http://dx.doi.org/10.31547/bct-2021-014 |
Ejemplares similares
-
Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
por: Nannya, Yasuhito, et al.
Publicado: (2022) -
Highlights of Pharmacist Roles in Hematopoietic Cell Transplantation and Cellular Therapy
por: Shi, Ho Ying, et al.
Publicado: (2021) -
Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation
por: Teshima, Takanori, et al.
Publicado: (2023) -
The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world
por: Okamoto, Shinichiro, et al.
Publicado: (2022) -
Role of Physical Activity and Cardiac Rehabilitation in Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Mohananey, Divyanshu, et al.
Publicado: (2021)